Genetics/Genomics News

The American College of Cardiology has announced the line-up of late-breaking clinical trials scheduled for presentation at its Annual Scientific Session and TCT@ACC-i2 summit.

Patients with a mutation in the gene encoding the enzyme glucokinase demonstrated a low prevalence for microvascular and macrovascular complications, research suggests.

Genetic susceptibility testing for the prevention and treatment of CVD is expected to be possible for individuals, families and populations in the near future, according to a scientific statement from the American Heart Association.

A gene variant that causes a hyperactive reaction to stress has been linked to a 38% increased risk for MI or death in patients with heart disease.

An increase in platelet reactivity was observed after red blood cell transfusion, which could explain post-transfusion spikes in ischemic events and mortality in patients with ACS, according to new study findings.

New applications for renal denervation and educational interventions for children about dietary behavior and physical activity will be among the biggest issues in cardiology in 2014, Valentin Fuster, MD, PhD, MACC, told Cardiology Today.

DALLAS — Two trials presented at AHA 2013, EU-PACT and COAG, yielded conflicting data on the utility of genetics in achievement of optimal warfarin dosing.

DALLAS — Two trials presented at AHA 2013, EU-PACT and COAG, yielded conflicting data on the utility of genetics in achievement of optimal warfarin dosing.

The Cardiology Today, Cardiology Today’s Intervention and Healio.com/Cardiology team will present live coverage from the American Heart Association 2013 Scientific Sessions, starting on Nov. 16.

A trial is underway to investigate whether antiplatelet therapy prescription based on a patient’s CYP2C19 genotype affects outcomes in patients undergoing PCI, according to an announcement from the Mayo Clinic.